Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire•05/11/2026•16:05 ET
0
Key Highlights
- ➤Faeth granted three new employees options for 68,000 shares.
- ➤Option exercise price is $19.99 per share.
- ➤Options vest over four years, subject to continued service.
- ➤Options carry ten-year terms under Faeth’s 2026 Inducement Plan.
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Faeth Therapeutics, Inc. (Nasdaq: FTH) today announced that the Compensation Committee of Faeth’s Board of Directors granted three new employees options to purchase an aggregate of 68,000 shares of the Company’s common stock in connection with their employment (collectively, the “Option Awards”). The Option Awards were granted effective November 4, 2026 pursuant to the Company’s 2026 Inducement Plan as a material inducement to the individuals entering employment with Faeth in accordance with Nasdaq Listing Rule 5635(c)(4).
Get started
Create a free account to read the full story.